Nicole A. Mortier

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Russell E. Ware, Barry R. Davis, William H. Schultz et al. · The Lancet · 2015 · 496 citations · Full text

Pediatric Hematology, Hematology, Neurological Monitoring +10

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

Sherri A. Zimmerman, William H. Schultz, Jacqueline S. Davis et al. · Blood · 2003 · 318 citations · Full text

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia

Sherri A. Zimmerman, William H. Schultz, Shelly Burgett et al. · Blood · 2007 · 218 citations

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy

Russell E. Ware, Sherri A. Zimmerman, Pamela B. Sylvestre et al. · The Journal of Pediatrics · 2004 · 173 citations

Thrombosis, Ischemic Stroke, Pediatric Hematology +14

Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia

Russell E. Ware, Jenny M. Despotovic, Nicole A. Mortier et al. · Blood · 2011 · 166 citations · Full text